Rxo (RXO) Total Debt (2022 - 2026)

Rxo (RXO) has reported Total Debt for 5 consecutive years, with $495.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Total Debt rose 22.83% year-over-year to $495.0 million; the trailing twelve-month figure through Jun 2026 stood at $495.0 million (up 22.83% YoY), and the FY2025 full-year result was $404.0 million, up 9.78% from the prior year.
• Total Debt grew to $495.0 million in Q2 2026 per RXO's latest filing, from $447.0 million in the prior quarter.
• Across five years, Total Debt topped out at $495.0 million in Q2 2026 and bottomed at $11.0 million in Q3 2022.
• Historically, Total Debt has averaged $389.6 million across 5 years, with a median of $403.5 million in 2025.
• The widest YoY moves for Total Debt: up 4027.27% in 2023, down 21.1% in 2023.
• Over 5 years, Total Debt stood at $455.0 million in 2022, then fell by 21.1% to $359.0 million in 2023, then rose by 2.51% to $368.0 million in 2024, then rose by 9.78% to $404.0 million in 2025, then climbed by 22.52% to $495.0 million in 2026.
• According to Business Quant data, Total Debt over the past three periods registered $495.0 million, $447.0 million, and $404.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.